A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer (Q39594730)

13 September 2017

A multi-institutional matched-control analysis of adjuvant and salvage postoperative radiation therapy for pT3-4N0 prostate cancer (English)

1 reference

adaptive radiation therapy

13 September 2017

0 references

1 reference

Mitchell S Anscher

12

0 references

Michael J Zelefsky

object named as

Michael J Zelefsky

9

0 references

Edouard J Trabulsi

1

object named as

Edouard J Trabulsi

1 reference

13 September 2017

6

Deborah A Kuban

1 reference

13 September 2017

10

Patrick A Kupelian

1 reference

13 September 2017

Richard K Valicenti

2

1 reference

13 September 2017

Alexandra L Hanlon

3

1 reference

13 September 2017

Thomas M Pisansky

4

1 reference

13 September 2017

Howard M Sandler

5

1 reference

13 September 2017

Charles N Catton

7

1 reference

13 September 2017

Jeff M Michalski

8

1 reference

13 September 2017

Daniel W Lin

11

1 reference

13 September 2017

Kevin M Slawin

13

1 reference

13 September 2017

Claus G Roehrborn

14

1 reference

13 September 2017

Jeffrey D Forman

15

1 reference

13 September 2017

Stanley L Liauw

16

1 reference

13 September 2017

Larry L Kestin

17

1 reference

13 September 2017

Theodore L DeWeese

18

1 reference

13 September 2017

Peter T Scardino

19

1 reference

13 September 2017

Andrew J Stephenson

20

1 reference

13 September 2017

Alan Pollack

21

1 reference

13 September 2017

language of work or name

English

0 references

publication date

30 July 2008

1 reference

13 September 2017

1 reference

13 September 2017

72

1 reference

13 September 2017

6

1 reference

13 September 2017

1298-302; discussion 1302-4

1 reference

Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy

13 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020432

Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020432

Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020432

Predominant treatment failure in postprostatectomy patients is local: analysis of patterns of treatment failure in SWOG 8794.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020432

Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020432

Effect of radiation therapy on detectable serum prostate specific antigen levels following radical prostatectomy: early versus delayed treatment.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020432

Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020432

Durable efficacy of early postoperative radiation therapy for high-risk pT3N0 prostate cancer: the importance of radiation dose

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020432

Pathologic seminal vesicle invasion after radical prostatectomy for patients with prostate carcinoma: effect of early adjuvant radiation therapy on biochemical control

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020432

Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule.

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020432

Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020432

Locally recurrent prostate tumors following either radiation therapy or radical prostatectomy have changes in Ki-67 labeling index, p53 and bcl-2 immunoreactivity

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4020432

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

21 August 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.05.057

The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.05.057

Adjuvant irradiation after radical prostatectomy for adenocarcinoma of prostate: analysis of freedom from PSA failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.05.057

Adjuvant radiotherapy following radical prostatectomy: results and complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.05.057

Adjuvant and salvage irradiation following radical prostatectomy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.05.057

Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.05.057

Toxicity following high-dose salvage radiotherapy after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.05.057

Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.05.057

Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3N0 prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2008.05.057

The multidisciplinary clinic approach to prostate cancer counseling and treatment

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18672274

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.UROLOGY.2008.05.057

1 reference

13 September 2017

1 reference

13 September 2017

PubMed publication ID

18672274

1 reference